Modulation of IL-1β reprogrammes the tumor microenvironment to interrupt oral carcinogenesis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wu, Tong ^a   Hong, Yun ^a   Jia, Lihua ^a   Wu, Jie ^a   Xia, Juan ^a   Wang, Juan ^a   Hu, Qinchao ^a   Cheng, Bin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; INTERLEUKIN 1BETA;

ANIMAL; BIOLOGICAL MODEL; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION; CHEMICALLY INDUCED; CLUSTER ANALYSIS; DISEASE MODEL; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; GENE EXPRESSION PROFILING; GENE SILENCING; GENETICS; MALE; METABOLISM; MOUTH MUCOSA; NEOPLASMS; ORAL DRUG ADMINISTRATION; PATHOLOGY; RAT; TUMOR CELL LINE; TUMOR MICROENVIRONMENT; XENOGRAFT;

4-NITROQUINOLINE-1-OXIDE; ADMINISTRATION, ORAL; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE SILENCING; HETEROGRAFTS; INTERLEUKIN-1BETA; MALE; MODELS, BIOLOGICAL; MOUTH MUCOSA; NEOPLASMS; RATS; TUMOR MICROENVIRONMENT;

EID: 84957576585     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20208     Document Type: Article

References (32)

1. Jemal, A. et al. Global cancer statistics. CA Cancer J Clin. 61, 69-90 (2011
2. Albers, A. E., Strauss, L., Liao, T., Hoffmann, T. K. &Kaufmann, A. M. T cell-tumor interaction directs the development of immunotherapies in head and neck cancer. Clin Dev Immunol. 2010, 236378 (2010
3. Hanahan, D. &Weinberg, R. A. Hallmarks of cancer: the next generation. Cell. 144, 646-74 (2011
4. Hanahan. D. &Coussens, L. M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 21, 309-22 (2012
5. Quail, D. F. &Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nature medicine. 19, 1423-37 (2013
6. Mueller, M. M. &Fusenig, N. E. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 4, 839-49 (2004
7. Kanojia, D. &Vaidya, M. M. 4-nitroquinoline-1-oxide induced experimental oral carcinogenesis. Oral Oncol. 42, 655-67 (2006
8. Dinarello, C. A. Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev. 29, 317-29 (2010
9. Albini, A. &Sporn, M. B. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer. 7, 139-47 (2007
10. Joyce, J. A. &Pollard, J. W. Microenvironmental regulation of metastasis. Nat Rev Cancer. 9, 239-52 (2009
11. Lando, M. et al. Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling. J Pathol. 230, 59-69 (2013
12. Lewis, A. M., Varghese, S., Xu, H. &Alexander, H. R. Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med. 4, 48 (2006
13. Chen, M. F. et al. Role of interleukin 1 beta in esophageal squamous cell carcinoma. J Mol Med (Berl90, 89-100 (2012
14. Duds, J. et al. Tumor-produced, active interleukin-1 regulates gene expression in carcinoma-Associated fibroblasts. Exp Cell Res. 317, 2222-9 (2011
15. Cas's, K. et al. Tumor cells induce COX-2 and mPGES-1 expression in microvascular endothelial cells mainly by means of IL-1 receptor activation. Microvasc Res. 81, 261-8 (2011
16. St John, M. A. et al. Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma. Clin Cancer Res. 15, 6018-27 (2009
17. Dong, G. W., Do, N. Y. &Lim, S. C. Relation between proinflammatory mediators and epithelial-mesenchymal transition in head and neck squamous cell carcinoma. Exp Ther Med. 1, 885-91 (2010
18. Lee, C. H. et al. IL-1 Promotes Malignant Transformation and Tumor Aggressiveness in Oral Cancer. J Cell Physiol. 230, 875-84 (2015
19. Hou, Z., Falcone, D. J., Subbaramaiah, K. &Dannenberg, A. J. Macrophages induce COX-2 expression in breast cancer cells: role of IL-1 autoamplification. Carcinogenesis. 32, 695-702 (2011
20. Lindahl, G., Saarinen, N., Abrahamsson, A. &Dabrosin, C. Tamoxifen, flaxseed, and the lignan enterolactone increase stroma-And cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer. Cancer Res. 71, 51-60 (2011
21. Triozzi, P. L., Aldrich, W. &Singh, A. Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma. Invest Ophthalmol Vis Sci. 52, 5529-35 (2011
22. Konishi, N. et al. Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma. Oncology. 68, 138-45 (2005
23. Lust, J. A. et al. Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component. Mayo Clin Proc. 84, 114-22 (2009
24. Elaraj, D. M. et al. The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clin Cancer Res. 12, 1088-96 (2006
25. Weinreich, D. M. et al. Effect of Interleukin 1 Receptor Antagonist Gene Transduction on Human Melanoma Xenografts in Nude Mice. Cancer Res. 63, 5957-61 (2003
26. Qian, L. et al. Recombinant human interleukin-1 receptor antagonist reduces acute lethal toxicity and protects hematopoiesis from chemotoxicity in vivo. Biomed Pharmacother. 67, 108-15 (2013
27. El-Osta, H., Janku, F. &Kurzrock, R. Successful treatment of Castleman's disease with interleukin-1 receptor antagonist (Anakinra). Mol Cancer Ther. 9, 1485-8 (2010
28. Hong, Y. et al. Frequent mutation of p16(CDKN2A) exon1 during rat tongue carcinogenesis induced by 4-nitroquinoline-1-oxide. Mol Carcinog. 46, 85-90 (2007
29. Zhang, C. et al. Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma. Clin Cancer Res. 15, 4017-27(2009
30. Vered, M., Allon, I., Buchner, A. &Dayan, D. Stromal myofibroblasts and malignant transformation in a 4NQO rat tongue carcinogenesis model. Oral Oncol. 43, 999-1006 (2007
31. Wu, T. et al. Genome-wide analysis reveals the active roles of keratinocytes in oral mucosal adaptive immune response. Exp Biol Med (Maywood). 236, 832-43 (2011
32. Guo, B. et al. Interaction network analysis of differentially expressed genes and screening of cancer marker in the urine of patients with invasive bladder cancer. Int J Clin Exp Med. 8, 3619-28 (2015